139 related articles for article (PubMed ID: 20127982)
21. An exon 1 deletion in OTC identified using chromosomal microarray analysis in a mother and her two affected deceased newborns: implications for the prenatal diagnosis of ornithine transcarbamylase deficiency.
Quintero-Rivera F; Deignan JL; Peredo J; Grody WW; Crandall B; Sims M; Cederbaum SD
Mol Genet Metab; 2010 Dec; 101(4):413-6. PubMed ID: 20817516
[TBL] [Abstract][Full Text] [Related]
22. Mutations and polymorphisms in the human ornithine transcarbamylase gene.
Tuchman M
Hum Mutat; 1993; 2(3):174-8. PubMed ID: 8364586
[TBL] [Abstract][Full Text] [Related]
23. Four newly identified ornithine transcarbamylase (OTC) mutations (D126G, R129H, I172M and W332X) in Japanese male patients with early-onset OTC deficiency.
Matsuura T; Hoshide R; Kiwaki K; Komaki S; Koike E; Endo F; Oyanagi K; Suzuki Y; Kato I; Ishikawa K
Hum Mutat; 1994; 3(4):402-6. PubMed ID: 8081398
[No Abstract] [Full Text] [Related]
24. An arginine to glutamine mutation in residue 109 of human ornithine transcarbamylase completely abolishes enzymatic activity in Cos1 cells.
Lee JT; Nussbaum RL
J Clin Invest; 1989 Dec; 84(6):1762-6. PubMed ID: 2556444
[TBL] [Abstract][Full Text] [Related]
25. Characterization of point mutations in the same arginine codon in three unrelated patients with ornithine transcarbamylase deficiency.
Maddalena A; Spence JE; O'Brien WE; Nussbaum RL
J Clin Invest; 1988 Oct; 82(4):1353-8. PubMed ID: 3170748
[TBL] [Abstract][Full Text] [Related]
26. Regulation of human prostate-specific G-protein coupled receptor, PSGR, by two distinct promoters and growth factors.
Weng J; Ma W; Mitchell D; Zhang J; Liu M
J Cell Biochem; 2005 Dec; 96(5):1034-48. PubMed ID: 16149059
[TBL] [Abstract][Full Text] [Related]
27. Analysis of mRNA transcripts improves the success rate of molecular genetic testing in OTC deficiency.
Engel K; Nuoffer JM; Mühlhausen C; Klaus V; Largiadèr CR; Tsiakas K; Santer R; Wermuth B; Häberle J
Mol Genet Metab; 2008 Jul; 94(3):292-7. PubMed ID: 18440262
[TBL] [Abstract][Full Text] [Related]
28. Six new mutations in the ornithine transcarbamylase gene detected by single-strand conformational polymorphism.
Tuchman M; Holzknecht RA; Gueron AB; Berry SA; Tsai MY
Pediatr Res; 1992 Nov; 32(5):600-4. PubMed ID: 1480464
[TBL] [Abstract][Full Text] [Related]
29. Promoter and 11-kilobase upstream enhancer elements responsible for hepatoma cell-specific expression of the rat ornithine transcarbamylase gene.
Murakami T; Nishiyori A; Takiguchi M; Mori M
Mol Cell Biol; 1990 Mar; 10(3):1180-91. PubMed ID: 2304462
[TBL] [Abstract][Full Text] [Related]
30. Gene Mutation Analysis and Prenatal Diagnosis of the Ornithine Transcarbamylase (OTC) Gene in Two Families with Ornithine Transcarbamylase Deficiency.
Li S; Cai Y; Shi C; Liu M; Liu B; Lin L; Xiao X; Hao H
Med Sci Monit; 2018 Oct; 24():7431-7437. PubMed ID: 30333473
[TBL] [Abstract][Full Text] [Related]
31. Characterization of novel promoter and enhancer elements of the mouse homologue of the Dent disease gene, CLCN5, implicated in X-linked hereditary nephrolithiasis.
Tanaka K; Fisher SE; Craig IW
Genomics; 1999 Jun; 58(3):281-92. PubMed ID: 10373326
[TBL] [Abstract][Full Text] [Related]
32. Expression analysis of two mutant human ornithine transcarbamylases in COS-7 cells.
Kogo T; Satoh Y; Kanazawa M; Yamamoto S; Takayanagi M; Ohtake A; Mori M; Niimi H
J Hum Genet; 1998; 43(1):54-8. PubMed ID: 9609999
[TBL] [Abstract][Full Text] [Related]
33. Hypocitrullinemia in expanded newborn screening by LC-MS/MS is not a reliable marker for ornithine transcarbamylase deficiency.
Cavicchi C; Malvagia S; la Marca G; Gasperini S; Donati MA; Zammarchi E; Guerrini R; Morrone A; Pasquini E
J Pharm Biomed Anal; 2009 Jul; 49(5):1292-5. PubMed ID: 19359120
[TBL] [Abstract][Full Text] [Related]
34. Proportions of spontaneous mutations in males and females with ornithine transcarbamylase deficiency.
Tuchman M; Matsuda I; Munnich A; Malcolm S; Strautnieks S; Briede T
Am J Med Genet; 1995 Jan; 55(1):67-70. PubMed ID: 7702100
[TBL] [Abstract][Full Text] [Related]
35. H intragenic polymorphisms and haplotype analysis in the ornithine transcarbamylase (OTC) gene and their relevance for tracking the inheritance of OTC deficiency.
Climent C; Rubio V
Hum Mutat; 2002 Nov; 20(5):407-8. PubMed ID: 12402347
[TBL] [Abstract][Full Text] [Related]
36. [Molecular diagnosis of OTC gene mutation in a Chinese family with ornithine transcarbamylase deficiency].
Meng LL; Jiang T; Qin L; Ma DY; Chen YL; Han SP; Yu ZB; Guo XR; Hu P; Xu ZF
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Apr; 30(2):195-8. PubMed ID: 23568734
[TBL] [Abstract][Full Text] [Related]
37. Studying on the 19-bp palindrome repeats in human cytomegalovirus immediate early enhancer/promoter reveals their diversity in function for the promoter activity.
Shen P; Niu G; Yao M; Wang H; Fei J
J Biochem; 2007 Jul; 142(1):25-31. PubMed ID: 17456501
[TBL] [Abstract][Full Text] [Related]
38. Functional characterization of the spf/ash splicing variation in OTC deficiency of mice and man.
Rivera-Barahona A; Sánchez-Alcudia R; Viecelli HM; Rüfenacht V; Pérez B; Ugarte M; Häberle J; Thöny B; Desviat LR
PLoS One; 2015; 10(4):e0122966. PubMed ID: 25853564
[TBL] [Abstract][Full Text] [Related]
39. Ornithine carbamoyltransferase deficiency: molecular characterization of 29 families.
Storkanova G; Vlaskova H; Chuzhanova N; Zeman J; Stranecky V; Majer F; Peskova K; Luksan O; Jirsa M; Hrebicek M; Dvorakova L
Clin Genet; 2013 Dec; 84(6):552-9. PubMed ID: 23278509
[TBL] [Abstract][Full Text] [Related]
40. Novel human pathological mutations. Gene symbol: OTC. Disease: ornithine transcarbamylase deficiency.
Lin HY; Lin HY; Lin SP
Hum Genet; 2010 Apr; 127(4):475. PubMed ID: 21488237
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
